A prospective, interventional, open-label clinical study to evaluate the safety and efficacy of KAL-HS-02 in reducing fatigue (Shrama), tiredness (Klama), improving strength (Balya), energy (Urjas) and enhancing quality of life (Swasthakara) among adult volunteers

Kerala Ayurveda Limited0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年1月9日

试验速览

暂无简介。

•1.Pregnant or Breast feeding.
•2.Inability to provide voluntary consent.
•3.Volunteers who have participated in any drug research study within past 3 months
•4.Patients with pre existing severe systemic disease like uncontrolled diabetes, hypertension, and Cardiac illness etc necessitating long term medication.
•5.Evidence of significant uncontrolled co morbid disease which in the investigators opinion would jeopardize patient participation.
•6.Any clinically significant medical history, medical finding or an ongoing medical or psychiatric condition exists which in the opinion of the Investigator could jeopardize the safety of the subject, impact validity of the study results or interfere with the completion of study according to the protocol.
•7.History of cancer, including solid tumors, hematologic malignancies and carcinoma in situ
•8.Use of any anti psychotic drugs in the past.
•9.Subjects who abuse drugs or alcohol
•10.Use of any investigational medication within 4 weeks prior to start of study drug

发起方